No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
The RORgamma modulator market is a subset of the larger immune disorder drugs market. RORgamma modulators are a type of drug that modulate the activity of the RORgamma protein, which is involved in the regulation of the immune system. These drugs are used to treat a variety of immune-related disorders, including autoimmune diseases, inflammatory diseases, and allergies.
RORgamma modulators are a relatively new class of drugs, and the market is still in its early stages. However, the potential of these drugs to treat a wide range of immune-related disorders has attracted the attention of many pharmaceutical companies.
Some of the major companies in the RORgamma modulator market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more
